Lantheus shareholders will receive up to $114.50 per share in cash under the definitive merger agreement.
Curium will acquire all outstanding shares of Lantheus Holdings (LNTH) for up to $114.50 per share in cash. The deal values Lantheus at a premium to its recent trading levels, reflecting strategic consolidation in the medical imaging sector.
Under the terms, Lantheus shareholders will receive $102.50 per share in cash at closing, with potential additional payments bringing the total to $114.50. The transaction follows a period of heightened M&A activity in healthcare, though no prior bids for Lantheus were publicly disclosed.
The agreement is expected to close in the first half of 2025, subject to regulatory and shareholder approvals.